STOCK TITAN

Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags

Allergan Aesthetics announces its sixth annual BOTOX® Cosmetic Day on November 20, featuring exclusive offers through the Allē rewards program. Following last year's record-breaking gift card sales, this year's celebration includes a Buy-One-Get-One Free gift card offer ($50 value), a Refer-a-Friend promotion worth $50, and a chance to win $10,000.

BOTOX® Cosmetic recently received FDA approval for treating platysma bands, making it the first neurotoxin with four aesthetic indications, including forehead lines, frown lines, and crow's feet lines. The Allē program serves over seven million members across nearly 30,000 practices, offering rewards on various aesthetic treatments and flexible payment options.

Allergan Aesthetics annuncia il suo sesto annuale BOTOX® Cosmetic Day il 20 novembre, con offerte esclusive attraverso il programma di premi Allē. A seguito delle vendite record di buoni regalo dello scorso anno, la celebrazione di quest'anno include un'offerta di acquisto uno e ricevi uno gratis (valore di $50), una promozione Refer-a-Friend del valore di $50 e la possibilità di vincere $10,000.

BOTOX® Cosmetic ha recentemente ricevuto l'approvazione della FDA per il trattamento delle bande platismali, rendendolo il primo neurotossina con quattro indicazioni estetiche, tra cui le linee della fronte, le linee della smorfia e le linee dei piedi di corvo. Il programma Allē serve oltre sette milioni di membri in quasi 30.000 pratiche, offrendo premi su vari trattamenti estetici e opzioni di pagamento flessibili.

Allergan Aesthetics anuncia su sexto Día de BOTOX® Cosmetic anual el 20 de noviembre, con ofertas exclusivas a través del programa de recompensas Allē. Después de las ventas récord de tarjetas de regalo del año pasado, la celebración de este año incluye una oferta de Compra Uno-Lleva Uno Gratis (valor de $50), una promoción Refer-a-Friend de $50 y la oportunidad de ganar $10,000.

BOTOX® Cosmetic recibió recientemente la aprobación de la FDA para tratar las bandas platismas, convirtiéndose en la primera neurotoxina con cuatro indicaciones estéticas, que incluyen líneas de la frente, líneas del ceño y patas de gallo. El programa Allē sirve a más de siete millones de miembros en casi 30,000 prácticas, ofreciendo recompensas en varios tratamientos estéticos y opciones de pago flexibles.

알레르간 미용에서는 11월 20일 제6회 BOTOX® Cosmetic Day를 발표하면서 Allē 보상 프로그램을 통한 독점 제안을 제공합니다. 지난해 기록적인 상품권 판매에 이어, 올해의 행사에는 구매 1개에 무료 1개 제공($50 가치) 및 친구 추천 프로모션($50 가치), $10,000를 받을 수 있는 기회가 포함됩니다.

BOTOX® Cosmetic은 최근 플라티스마 밴드 치료에 대한 FDA 승인을 받아 이마 주름, 찡글 주름, 까마귀 발 주름을 포함한 네 가지 미용 적응증을 가진 최초의 신경 독소가 되었습니다. Allē 프로그램은 약 30,000개의 실습에서 700만 명 이상의 회원에게 서비스를 제공하며, 다양한 미용 치료에 대한 보상과 유연한 지불 옵션을 제공합니다.

Allergan Aesthetics annonce son sixième Jour du BOTOX® Cosmetic annuel le 20 novembre, avec des offres exclusives via le programme de récompenses Allē. Suite aux ventes record de cartes-cadeaux de l'année dernière, la célébration de cette année comprend une offre de type « Achetez-en un, obtenez-en un gratuit » (valeur de 50 $), une promotion « Parrainez un ami » d'une valeur de 50 $ et une chance de gagner 10 000 $.

BOTOX® Cosmetic a récemment reçu l'approbation de la FDA pour traiter les bandes platismales, devenant ainsi le premier neurotoxine avec quatre indications esthétiques, y compris les rides du front, les rides du froncement de sourcils et les pattes d'oie. Le programme Allē sert plus de sept millions de membres dans près de 30 000 pratiques, offrant des récompenses sur divers traitements esthétiques et des options de paiement flexibles.

Allergan Aesthetics kündigt seinen sechsten jährlichen BOTOX® Cosmetic Day am 20. November an, mit exklusiven Angeboten über das Allē-Belohnungsprogramm. Nach den rekordbrechenden Verkaufszahlen von Geschenkkarten im letzten Jahr umfasst die diesjährige Feier ein Angebot „Kaufe Eins, Bekomme Eins Gratis“ (Wert von $50), eine „Freund-werben-Freund“-Aktion im Wert von $50 und die Chance, $10.000 zu gewinnen.

BOTOX® Cosmetic erhielt kürzlich die FDA-Zulassung zur Behandlung von Platysma-Bändern und ist somit das erste Neurotoxin mit vier ästhetischen Indikationen, einschließlich Stirnfalten, Zornfalten und Krähenfußlinien. Das Allē-Programm bedient über sieben Millionen Mitglieder in nahezu 30.000 Praxen und bietet Belohnungen für verschiedene ästhetische Behandlungen und flexible Zahlungsoptionen.

Positive
  • None.
Negative
  • None.
  • Last Year, BOTOX® Cosmetic Day Set the Record for the Most BOTOX® Cosmetic Gift Cards Sold in a Single Day1
  • This Year, the Excitement Continues with New Offers to Refer a Friend Plus the Best-Selling Buy-One-Get-One (BOGO) Free Gift Card Offer
  • Join Allē Today to Take Advantage of Exclusive Offers

IRVINE, Calif., Nov. 7, 2024 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that the sixth annual BOTOX® Cosmetic Day will be Wednesday, November 20. This holiday continues to celebrate the health care providers and patients that have made BOTOX® Cosmetic the number one selling neurotoxin globally.2 Following its recent FDA approval for the temporary improvement in the appearance of moderate to severe vertical bands connecting the jaw and neck (platysma bands) in adults, BOTOX® Cosmetic is now the first and only product of its kind with four aesthetic indications: moderate to severe forehead lines, frown lines, crow's feet lines, and now platysma bands in adults.3

"Last year, we saw record-breaking engagement around BOTOX® Cosmetic Day, with the highest number of gift cards ever sold1," said Carrie Strom, President Allergan Aesthetics and SVP AbbVie. "This year, we're back with even more new offers through Allē, the Allergan Aesthetics loyalty rewards program. We're thrilled to celebrate this year's BOTOX® Cosmetic Day with our customers and patients who've made it all possible."

Celebrate BOTOX® Cosmetic Day with exclusive offers available through Allē:

  • BOGO Free Gift Card: On Wednesday, November 20, starting at 9 am Pacific Time and while supplies last, Allē Members who buy a $50 gift card will get a $50 gift card for free, to use for themselves or to gift to others, for a discount on future treatments with participating Allē providers*
  • Refer a Friend: Refer a friend to Allē November 1-30 and you'll both get $50 off a BOTOX® Cosmetic treatment*
  • Win $10,000: Register by November 30, book a consultation, and get treated with BOTOX® Cosmetic for a chance to win $10,000†
  • When you take advantage of the BOGO and Refer a Friend offers, you can save up to $100 off BOTOX® Cosmetic plus enter for a chance to win $10,000

"At my practice, we leverage Allē to ensure BOTOX® Cosmetic Day is successful for patients looking to explore the results that can be achieved with BOTOX® Cosmetic," said Dr. David Shafer, double board-certified plastic surgeon and Allergan Medical Institute (AMI) trainer. "BOTOX® Cosmetic Day, and all of November, offers a fun and engaging opportunity for appropriate patients to experience BOTOX® Cosmetic, helping them look like themselves, just with fewer lines."

Anyone interested in learning more about BOTOX® Cosmetic treatment is encouraged to visit botoxcosmetic.com and enroll in Allē, the Allergan Aesthetics loyalty rewards program. In serving more than seven million Members across nearly 30,000 practices to date, part of Allē's mission is to help educate consumers about aesthetic treatments and to simplify office operations for practices. From its inception, Allē has offered the most robust rewards program in aesthetics and is the first and only aesthetics loyalty program to also offer consumers the ability to earn points on over 50 non-Allergan Aesthetics treatments and brands. By providing Members with information, tools, incentives, and now with flexible ways to pay through Allē Payment Plans powered by Cherry, Allē empowers consumers along their treatment journey, making the next product purchase or treatment closer within reach. 

Recognized by National Day Archives as an official holiday on the National Day Registry™, BOTOX® Cosmetic Day is held annually on the third Wednesday in November.

To learn more, join Allē at alle.com/botoxcosmeticday or follow @botoxcosmetic on Instagram and YouTube.

*BOGO and Refer a Friend offers are limited time only and while supplies last. Terms and Conditions apply. Maximum of one referral offer per Member. To get a $50 offer for your referral, we need your friend's approval. Without it, we won't be able to reward you. Your friend must get treated and purchase must be made in the first 60 days of account registration for you to qualify. See Allē app for full Terms and Conditions.

NO PURCHASE NECESSARY. Open to Allē Members in 50 U.S./D.C.; 18+ (19+ in AL, NE; 21+ in MS). You must register online prior to treatment between 12:00:01 AM PT on 11/1/24 and 7:59:59 PM PT on 11/30/24. Treatment must occur by 12/6/24. See Official Rules for all details and how to enter without purchase at https://alle.com/lp/botoxcosmeticdaysweeps-official-rules.

Payment options through Cherry Technologies, Inc. are issued by the following lending partners: www.withcherry.com/lending-partners/. Term length, approval amount, 0% APR and other promotional rates are subject to eligibility. See www.withcherry.com/terms for details. Iowa only: Borrowers are subject to Iowa state specific underwriting criteria. APR for all Iowa borrowers is capped at 20.99%.

About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.allerganaesthetics.com.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

Approved Uses
BOTOX® Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe forehead lines, crow's feet lines, frown lines between the eyebrows, and vertical bands connecting the jaw and neck (platysma bands) in adults.

IMPORTANT SAFETY INFORMATION
BOTOX® Cosmetic may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX® Cosmetic:

  • Problems swallowing, speaking, or breathing, due to weakening of associated muscles, which can be severe and result in loss of life. You are at the highest risk if these problems are preexisting before injection. Swallowing problems may last for several months.
  • Spread of toxin effects. The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms, including loss of strength and all-over muscle weakness, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, and trouble swallowing.

BOTOX® Cosmetic dosing units are not the same as, or comparable to, any other botulinum toxin product.

There has not been a confirmed serious case of spread of toxin effect when BOTOX® Cosmetic has been used at the recommended dose to treat frown lines, crow's feet lines, forehead lines, and/or platysma bands.

BOTOX® Cosmetic may cause loss of strength or general muscle weakness, vision problems, or dizziness within hours to weeks of receiving BOTOX® Cosmetic. If this happens, do not drive a car, operate machinery, or do other dangerous activities.

Serious and/or immediate allergic reactions have been reported, including itching, rash, red itchy welts, wheezing, asthma symptoms, or dizziness or feeling faint. Get medical help right away if you are wheezing or have asthma symptoms, or if you become dizzy or faint.

Do not receive BOTOX® Cosmetic if you are allergic to any of the ingredients in BOTOX® Cosmetic (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc (rimabotulinumtoxinB), Dysport (abobotulinumtoxinA), Xeomin (incobotulinumtoxinA), Jeuveau (prabotulinumtoxinA-xvfs), Daxxify (daxibotulinumtoxinA-lanm), or Letybo (letibotulinumtoxinA-wlbg); or have a skin infection at the planned injection site. This list may not include all available botulinum toxin products.

Tell your doctor about all your muscle or nerve conditions, such as ALS or Lou Gehrig's disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at increased risk of serious side effects, including difficulty swallowing and difficulty breathing, from standard doses of BOTOX® Cosmetic.

Tell your doctor about all your medical conditions, including surgery or plans to have surgery on your face, trouble raising your eyebrows, drooping eyelids, any other abnormal facial change, are pregnant or plan to become pregnant (it is not known if BOTOX® Cosmetic can harm your unborn baby), or are breastfeeding or plan to (it is not known if BOTOX® Cosmetic passes into breast milk).

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX® Cosmetic with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received BOTOX® Cosmetic in the past.

Tell your doctor if you have received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin such as Myobloc, Dysport, Xeomin, Jeuveau, Daxxify, or Letybo in the past (tell your doctor exactly which product you received); have recently received an antibiotic by injection; take muscle relaxants; take an allergy or cold medicine; take a sleep medicine; or take aspirin-like products or blood thinners.

Other side effects of BOTOX® Cosmetic include dry mouth; discomfort or pain at the injection site; tiredness; headache; neck pain; and eye problems, including double vision, blurred vision, decreased eyesight, drooping eyelids and eyebrows, swelling of eyelids, and dry eyes.

For more information, refer to the Medication Guide or talk with your doctor.

To report a side effect, please call Allergan Aesthetics at 1-800-678-1605.
Please see BOTOX® Cosmetic full Prescribing Information, including Boxed Warning and Medication Guide.

References:

  1. Data on File. Allergan. November 2023.
  2. Data on File. AbbVie. Neurotoxin Monthly Tracker Report, 2023.
  3. BOTOX® Cosmetic Prescribing Information, October 2024.

© 2024 AbbVie. All rights reserved. BOTOX Cosmetic and its designs are trademarks of Allergan Holdings France SAS, an AbbVie company, or its affiliates.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/allergan-aesthetics-celebrates-annual-botox-cosmetic-onabotulinumtoxina-day-302298114.html

SOURCE AbbVie

FAQ

When is BOTOX Cosmetic Day 2024 (ABBV)?

BOTOX Cosmetic Day 2024 will be celebrated on Wednesday, November 20, as announced by Allergan Aesthetics.

What offers are available on BOTOX Cosmetic Day 2024 (ABBV)?

The offers include a BOGO free gift card ($50 value), a $50 Refer-a-Friend promotion, and a chance to win $10,000 through the Allē rewards program.

What new FDA approval did BOTOX Cosmetic (ABBV) receive?

BOTOX Cosmetic received FDA approval for treating platysma bands, becoming the first neurotoxin with four aesthetic indications.

How many members does the Allē rewards program have (ABBV)?

The Allē rewards program serves more than seven million members across nearly 30,000 practices.

ABBVIE INC.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

306.72B
1.77B
0.1%
73.45%
1.14%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NORTH CHICAGO